Microglia: a sensor to threats in the nervous system? - PubMed (original) (raw)
Review
Microglia: a sensor to threats in the nervous system?
J Gehrmann. Res Virol. 1996 Mar-Jun.
Abstract
The parenchymal microglia are now believed to settle the CNS antenatally, being derived from a bone marrow precursor cell. Based on developmental and pathophysiological studies, at least four different types of parenchymal microglia can be distinguished: (i) the amoeboid microglia which are mainly found perinatally in white matter areas, such as the corpus callosum, i.e. the so-called "fountains of microglia", (ii) the ramified, resting microglia in the adult CNS, (iii) the activated, non-phagocytic microglia found in areas of secondary reaction due to nerve transection and (iv) the phagocytic microglia, found in areas of trauma, infection or neuronal necrosis. In addition, there are perivascular cells enclosed in the basal lamina which have a high turnover with a bone marrow precursor pool. While the function of resting microglia is still largely unknown, it is clear from observations in neuropathology that microglia are among the first cell types in the brain to respond to injuries. Their reaction pattern to injury has been termed a graded response, since the transformation of resting cells into phagocytes is under strict control in vivo. Microglial activation is a key cellular response in many infectious, inflammatory, traumatic, neoplastic, ischaemic and degenerative conditions in the CNS. In HIV encephalitis, the microglial involvement is striking, and approximately 25% of microglia contain viral DNA or RNA. Based on natural homing mechanisms with bone marrow precursor cells, HIV-infected monocytes/macrophages may home at an early stage to the CNS perivascular space and eventually spread the infection to resident microglia in the CNS which may be difficult to reach by pharmacological intervention. Further understanding of the mechanisms regulating microglial proliferation and activation in vivo may help to develop therapies targeting the potentially harmful microglial response in the injured CNS.
Similar articles
- Microglia: intrinsic immuneffector cell of the brain.
Gehrmann J, Matsumoto Y, Kreutzberg GW. Gehrmann J, et al. Brain Res Brain Res Rev. 1995 Mar;20(3):269-87. doi: 10.1016/0165-0173(94)00015-h. Brain Res Brain Res Rev. 1995. PMID: 7550361 Review. - GM-CSF and M-CSF modulate beta-chemokine and HIV-1 expression in microglia.
Si Q, Cosenza M, Zhao ML, Goldstein H, Lee SC. Si Q, et al. Glia. 2002 Aug;39(2):174-83. doi: 10.1002/glia.10095. Glia. 2002. PMID: 12112368 - Transformation of donor-derived bone marrow precursors into host microglia during autoimmune CNS inflammation and during the retrograde response to axotomy.
Flügel A, Bradl M, Kreutzberg GW, Graeber MB. Flügel A, et al. J Neurosci Res. 2001 Oct 1;66(1):74-82. doi: 10.1002/jnr.1198. J Neurosci Res. 2001. PMID: 11599003 - Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1 in HIV-1 encephalitis.
Cosenza MA, Zhao ML, Si Q, Lee SC. Cosenza MA, et al. Brain Pathol. 2002 Oct;12(4):442-55. doi: 10.1111/j.1750-3639.2002.tb00461.x. Brain Pathol. 2002. PMID: 12408230 Free PMC article. - Microglial activation and its implications in the brain diseases.
Dheen ST, Kaur C, Ling EA. Dheen ST, et al. Curr Med Chem. 2007;14(11):1189-97. doi: 10.2174/092986707780597961. Curr Med Chem. 2007. PMID: 17504139 Review.
Cited by
- Potential immunotherapies for traumatic brain and spinal cord injury.
Putatunda R, Bethea JR, Hu WH. Putatunda R, et al. Chin J Traumatol. 2018 Jun;21(3):125-136. doi: 10.1016/j.cjtee.2018.02.002. Epub 2018 Apr 18. Chin J Traumatol. 2018. PMID: 29759918 Free PMC article. Review. - Cannabinoids inhibit migration of microglial-like cells to the HIV protein Tat.
Fraga D, Raborn ES, Ferreira GA, Cabral GA. Fraga D, et al. J Neuroimmune Pharmacol. 2011 Dec;6(4):566-77. doi: 10.1007/s11481-011-9291-6. Epub 2011 Jul 7. J Neuroimmune Pharmacol. 2011. PMID: 21735070 - Development of NMDAR antagonists with reduced neurotoxic side effects: a study on GK11.
Vandame D, Ulmann L, Teigell M, Prieto-Cappellini M, Vignon J, Privat A, Perez-Polo R, Nesic O, Hirbec H. Vandame D, et al. PLoS One. 2013 Nov 19;8(11):e81004. doi: 10.1371/journal.pone.0081004. eCollection 2013. PLoS One. 2013. PMID: 24260528 Free PMC article. - CB2 receptors in the brain: role in central immune function.
Cabral GA, Raborn ES, Griffin L, Dennis J, Marciano-Cabral F. Cabral GA, et al. Br J Pharmacol. 2008 Jan;153(2):240-51. doi: 10.1038/sj.bjp.0707584. Epub 2007 Nov 26. Br J Pharmacol. 2008. PMID: 18037916 Free PMC article. Review. - Neurons and astroglia govern microglial endotoxin tolerance through macrophage colony-stimulating factor receptor-mediated ERK1/2 signals.
Chu CH, Wang S, Li CL, Chen SH, Hu CF, Chung YL, Chen SL, Wang Q, Lu RB, Gao HM, Hong JS. Chu CH, et al. Brain Behav Immun. 2016 Jul;55:260-272. doi: 10.1016/j.bbi.2016.04.015. Epub 2016 Apr 27. Brain Behav Immun. 2016. PMID: 27132056 Free PMC article.